Latest News

Page 1 of 3012345...102030...Last »

August 11, 2018

Danger of Blue Light From Screens May Be Overstated

Posted in: Daily Living, Latest News

by Dan Roberts In view of a recent surge in media reporting about blue light damage from digital devices, it is important to remember that there is no scientific evidence that blue light from such devices causes eye damage. The sun, and full spectrum lamps which imitate the sun, are the two strongest and most common
read more »

July 29, 2018

Let’s All Go to the Movies!

Posted in: Daily Living, Latest News

As of June 2, 2018, the law requires that audio description for the blind and visually impaired be made available by all digital first-run movie theaters. Almost all applicable theaters have complied, and others are in the process of converting to digital and upgrading to include description equipment. The Federal Government defines audio description as
read more »

July 26, 2018

New Port Delivery System Unveiled for Wet AMD Treatment

Posted in: Latest News, Research and Developments

Genentech has announced positive, top line results from a Phase 2 study of its Port Delivery System (PDS) with Lucentis in people with wet age-related macular degeneration (AMD). The small, refillable eye implant, which is slightly longer than a grain of rice, is designed to allow people with wet AMD to go several months without
read more »

July 20, 2018

Abicipar for Wet AMD May Extend Time Between Treatments

Posted in: Latest News, Research and Developments

Allergan and Molecular Partners have announced the release of two positive clinical trials of a new treatment for wet age-related macular degeneration (wAMD). The trials, named SEQUOIA and CEDAR, demonstrated that the biological drug Abicipar is equal to Genentech’s Lucentis (ranibizumab), with the added benefit that Abicipar treatments are effective at up to 12-week dosages.
read more »

July 19, 2018

Emixustat Found Ineffective

Posted in: Latest News, Research and Developments

The drug Emixustat has been in Phase 1/2 trials since 2008 for treatment of dry macular degeneration. Disappointingly, the drug has now been found to be ineffective at reducing the growth rates of geographic atrophy (GA) in patients with age-related macular degeneration (AMD). Preclinical analysis of Emixustat indicated that it inhibited the activity of the
read more »

July 2, 2018

Suffering From Dry Eye?

Posted in: Eye Conditions, Latest News, Therapies, Treatments, and Procedures

Age-related macular degeneration (AMD) is the most common cause of visual impairment in people over age 60. Because it affects millions of senior adults, it deserves a great deal of attention. Another common condition also deserving of consideration is dry eye. Dry eye often accompanies AMD, but only because it most commonly affects the same
read more »

July 2, 2018

Protect Your Eyes From Fireworks Injuries

Posted in: Latest News

Prevent Blindness wants all Americans to know that 14% of all injuries from fireworks are to the eyes, and that contusions, lacerations, and foreign bodies in the eyes occurred more frequently than burns to other parts of the body. Here are more important statistics from the U.S. Consumer Product Safety Commission: Fireworks devices were involved
read more »

May 19, 2018

Summary of Research and Development — 2018

Posted in: Health and Nutrition, Latest News, Research and Developments, Therapies, Treatments, and Procedures

Transcript of a presentation to the International Low Vision Support Group June 2018 Dan Roberts, Director Select this link for audio-visual format INTRODUCTION This is our 13th annual summary of leading research and developments occuring during the past 12 months in the fields of blindness and low vision. Sources for further information will appear beneath
read more »

May 16, 2018

Every Patient Can Be an Advocate

Posted in: Daily Living, Latest News

by Dan Roberts What do these six famous people have in common?           They are all different in many ways, but they each possess at least one characteristic which sets them apart. They have a strong sense of empathy, making it impossible for them to remain silent in the face of
read more »

April 25, 2018

Müller Cells Might Be Re-programmed to Become Sight Cells

Posted in: Latest News, Research and Developments

Degeneration of photoreceptors (rod and cone cells) is a leading cause of vision loss. Since there are no effective treatments to restore vision once photoreceptors are lost, photoreceptor regeneration has the very real prospect of alleviating blindness in these eyes. To that end, a recent innovative study has demonstrated the possibility of reprogramming Müller glial
read more »

Page 1 of 3012345...102030...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann